Evidence map›Paper›PMID 35496387›Full record

ArticleRSC advances2021

H

Fan Zhao, Jing Yu, Weiliang Gao, Xue Yang, Liying Liang, Xiaolian Sun, Dan Su, Yao Ying, Wangchang Li, Juan Li and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Fan ZhaoCollege of Materials Science and Engineering, Zhejiang University of Technology Hangzhou 310014 China yujing@zjut.edu.cn cheshenglei@zjut.edu.cn.
Jing YuCollege of Materials Science and Engineering, Zhejiang University of Technology Hangzhou 310014 China yujing@zjut.edu.cn cheshenglei@zjut.edu.cn.ORCID https://orcid.org/0000-0002-8694-8948
Weiliang GaoCollege of Materials Science and Engineering, Zhejiang University of Technology Hangzhou 310014 China yujing@zjut.edu.cn cheshenglei@zjut.edu.cn.
Xue YangClinical Research Institute, Zhejiang Provincial People's Hospital Hangzhou 310014 China mouxz@zju.edu.cn.
Liying LiangCollege of Materials Science and Engineering, Zhejiang University of Technology Hangzhou 310014 China yujing@zjut.edu.cn cheshenglei@zjut.edu.cn.
Xiaolian SunKey Laboratory of Drug Quality Control and Pharmacovigilance (China Pharmaceutical University), Ministry of Education Nanjing 210009 China.
Dan SuDepartment of Oncology, Zhejiang Provincial People's Hospital Hangzhou 310014 China.
Yao YingCollege of Materials Science and Engineering, Zhejiang University of Technology Hangzhou 310014 China yujing@zjut.edu.cn cheshenglei@zjut.edu.cn.ORCID https://orcid.org/0000-0001-7069-3795
Wangchang LiCollege of Materials Science and Engineering, Zhejiang University of Technology Hangzhou 310014 China yujing@zjut.edu.cn cheshenglei@zjut.edu.cn.
Juan LiCollege of Materials Science and Engineering, Zhejiang University of Technology Hangzhou 310014 China yujing@zjut.edu.cn cheshenglei@zjut.edu.cn.
Jingwu ZhengCollege of Materials Science and Engineering, Zhejiang University of Technology Hangzhou 310014 China yujing@zjut.edu.cn cheshenglei@zjut.edu.cn.
Liang QiaoCollege of Materials Science and Engineering, Zhejiang University of Technology Hangzhou 310014 China yujing@zjut.edu.cn cheshenglei@zjut.edu.cn.
Wei CaiCollege of Materials Science and Engineering, Zhejiang University of Technology Hangzhou 310014 China yujing@zjut.edu.cn cheshenglei@zjut.edu.cn.
Shenglei CheCollege of Materials Science and Engineering, Zhejiang University of Technology Hangzhou 310014 China yujing@zjut.edu.cn cheshenglei@zjut.edu.cn.ORCID https://orcid.org/0000-0001-5086-8551
Xiaozhou MouClinical Research Institute, Zhejiang Provincial People's Hospital Hangzhou 310014 China mouxz@zju.edu.cn.
Zhejiang University of Technology · CNZhejiang Provincial People's Hospital · CNChina Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemodynamic therapy (CDT) is a booming technology that utilizes Fenton reagents to kill tumor cells by transforming intracellular H

Identifiers

PMID35496387
PMCPMC9043768
OpenAlexW3216101099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.